SCHEMBL4124770

SCHEMBL4124770

COC(=O)c1ccc2c(C3CCCCC3)c(Br)n(CCO[Si](C)(C)C(C)(C)C)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 5/20 0.37
ALDH1A1 P00352 6/20 0.36
NPSR1 Q6W5P4 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
RXFP1 Q9HBX9 2/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NQO2 P16083 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ATM Q13315 1/20 0.35
GAA P10253 2/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3722315 0.95 SCARB1 (0.37) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL772086 0.85 KMT2A (0.40) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL772730 0.84 PKM (0.43) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL3722589 0.83 ALDH1A1 (0.39) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL773119 0.83 JAK2 (0.42) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL771593 0.83 SCN9A (0.40) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL3073515 0.82 ALDH1A1 (0.40) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL3085979 0.82 ALDH1A1 (0.40) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL4827972 0.81 ALDH1A1 (0.42) SCN9AALDH1A1NPSR1KDM4EHPGD
SCHEMBL773128 0.80 CNR2 (0.41) SCN9AALDH1A1NPSR1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090197856-A1 ANTIVIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197856-A1 ANTIVIRAL COMPOUNDS ZC3HAV1, EIF2AK2, MAVS SCN9A 2151/4885ALDH1A1 2216/4885NPSR1 3764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.